Semiautomated typing of human papillomaviruses by restriction fragment length polymorphism analysis of fluorescence-labeled PCR fragments
A simplified version of a PCR‐based reductional restriction fragment length polymorphism (rRFLP) approach for typing of human papillomaviruses (HPVs) is described previously [Wang et al., 1997]. It is achieved by the use of a biotin‐labeled primer in PCR which, on restriction digestion and staining,...
Saved in:
Published in | Journal of medical virology Vol. 59; no. 4; pp. 536 - 540 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
New York
John Wiley & Sons, Inc
01.12.1999
Wiley-Liss |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A simplified version of a PCR‐based reductional restriction fragment length polymorphism (rRFLP) approach for typing of human papillomaviruses (HPVs) is described previously [Wang et al., 1997]. It is achieved by the use of a biotin‐labeled primer in PCR which, on restriction digestion and staining, is associated with only a single restriction fragment. In this report, we describe a further development of the rRFLP approach with the use of a fluorescence‐labeled primer in PCR and fragment detection by laser scanning in an automatic sequencer. HPV typing is achieved by computer‐assisted matching of the fluorescence‐labeled rRFLP patterns with a database of rRFLP patterns of all known anogenital HPV types. On analysis of the typing of 133 HPV‐positive cases using this procedure, 20 different HPV types were detected in exfoliated cervical cells in PAP smear samples derived from Taiwanese women. The results indicate the existence of a heterogeneous population of HPV types in Taiwan. Although most cases were associated with the more common HPV types, a significant fraction (about 20%) of the HPV types detected was related to the less common genotypes, which are often not included in commercial kits available for HPV typing. The results indicate the importance of covering as many HPV types as possible in clinical HPV genotyping protocols. J. Med. Virol. 59:536–540, 1999. © 1999 Wiley‐Liss, Inc. |
---|---|
Bibliography: | ark:/67375/WNG-ZLPR09ZD-7 istex:A09E69AFFBC83D45701AB7078E47F1267CB52A9D the Veterans General Hospital-Taipei - No. VGH87-402 ArticleID:JMV18 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0146-6615 1096-9071 |
DOI: | 10.1002/(SICI)1096-9071(199912)59:4<536::AID-JMV18>3.0.CO;2-T |